FDA inspection
Ranbaxy Inc.: FDA inspection ending Jun 20, 2017
FDA inspection 1018135 · No Action Indicated (NAI) · Princeton, NJ
Key facts
| Inspection ID | 1018135 |
|---|---|
| Firm | Ranbaxy Inc. |
| FEI number | 3003476632 |
| Address | 600 College Rd E Ste 2100 |
| City | Princeton |
| State | NJ |
| ZIP | 08540 |
| Country | United States |
| Fiscal year | 2017 |
| Inspection end date | Jun 20, 2017 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data